CIRM Directors to Take Up Future Funding and Direction of Stem Cell Agency

The meeting of the CIRM board has recessed for five minutes. When it resumes directors will begin discussing their desires for future direction of CIRM and the "transition plan" for the agency as it loses its funding in about five years.